Pharmaceutical Products Companies By Gross Profit

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Gross Profit
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Gross ProfitEfficiencyMarket RiskExp Return
1TLX Telix Pharmaceuticals Limited
405.35 M
 0.10 
 2.87 
 0.28 
2MIRM Mirum Pharmaceuticals
223.14 M
 0.13 
 2.51 
 0.32 
3MNKD MannKind Corp
192.14 M
(0.05)
 2.39 
(0.13)
4VCEL Vericel Corp Ord
162.12 M
 0.25 
 2.51 
 0.62 
5DVAX Dynavax Technologies
161.93 M
 0.10 
 2.26 
 0.23 
6MRVI Maravai Lifesciences Holdings
128.38 M
(0.09)
 7.01 
(0.66)
7ME 23Andme Holding Co
89.21 M
(0.05)
 6.11 
(0.31)
8DTIL Precision BioSciences
75.1 M
(0.10)
 7.00 
(0.71)
9MDGL Madrigal Pharmaceuticals
74.03 M
 0.13 
 5.08 
 0.68 
10MEIP MEI Pharma
49.33 M
 0.04 
 2.67 
 0.11 
11EQ Equillium
42.62 M
(0.08)
 7.35 
(0.61)
12XOMAP XOMA Corp
37.99 M
(0.03)
 0.70 
(0.02)
13XOMAO XOMA Corporation
37.99 M
 0.03 
 0.31 
 0.01 
14SNYR Synergy CHC Corp
25.65 M
 0.05 
 16.79 
 0.86 
15MCRB Seres Therapeutics
23.26 M
 0.01 
 6.00 
 0.09 
16MGTX MeiraGTx Holdings PLC
8.12 M
 0.04 
 3.49 
 0.13 
17DNTH Dianthus Therapeutics
5.37 M
(0.12)
 4.20 
(0.48)
18VERU Veru Inc
4.71 M
 0.06 
 5.21 
 0.32 
19MDWD Mediwound
2.67 M
 0.03 
 3.11 
 0.10 
20NWBO Northwest Biotherapeutics
1 M
 0.02 
 4.09 
 0.08 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY